
Quantum-Si Incorporated (NASDAQ:QSI – Free Report) – Research analysts at HC Wainwright increased their FY2026 earnings estimates for shares of Quantum-Si in a research note issued to investors on Thursday, November 12th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.42) per share for the year, up from their previous forecast of ($0.47). HC Wainwright has a “Buy” rating on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.42) per share. HC Wainwright also issued estimates for Quantum-Si’s Q4 2026 earnings at ($0.11) EPS, Q1 2027 earnings at ($0.11) EPS and FY2027 earnings at ($0.41) EPS.
Quantum-Si (NASDAQ:QSI – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative net margin of 6,729.80% and a negative return on equity of 44.72%. The firm had revenue of $0.21 million during the quarter, compared to analysts’ expectations of $0.27 million.
Get Our Latest Stock Report on QSI
Quantum-Si Stock Performance
NASDAQ QSI opened at $1.15 on Monday. The firm has a market cap of $252.70 million, a PE ratio of -2.95 and a beta of 3.26. Quantum-Si has a one year low of $0.69 and a one year high of $1.81. The firm’s fifty day moving average is $1.14 and its two-hundred day moving average is $0.97.
Institutional Investors Weigh In On Quantum-Si
Several hedge funds have recently modified their holdings of QSI. IPG Investment Advisors LLC purchased a new position in Quantum-Si in the 2nd quarter valued at $27,000. Commonwealth Equity Services LLC acquired a new position in Quantum-Si in the 3rd quarter valued at $29,000. Hollencrest Capital Management increased its stake in Quantum-Si by 301.1% in the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after buying an additional 30,111 shares during the period. Corient Private Wealth LP purchased a new position in Quantum-Si during the 2nd quarter worth $34,000. Finally, China Universal Asset Management Co. Ltd. purchased a new position in Quantum-Si during the 3rd quarter worth $39,000. 39.90% of the stock is owned by institutional investors and hedge funds.
About Quantum-Si
Quantum-Si is a life sciences technology company developing tools for protein sequencing and proteomics research. Its platform uses semiconductor technology and single-molecule detection to analyze proteins, with the aim of making protein-level information more accessible to researchers. The company’s offerings include the Platinum benchtop instrument, along with consumables, reagents and software used to prepare, run and analyze samples. Quantum-Si’s products are designed for research applications in areas such as drug discovery and biological research.
See Also
- Five stocks we like better than Quantum-Si
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
